ARTHUR DAVID J. (Chief Executive Officer) purchased 4.1% of their position (4K shares) of DECOY THERAPEUTICS INC. on the open market
Open‑market purchase worth $3.6K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/17/2021ACC: 0001615219-21-000087
DirectorOfficer· Chief Executive Officer
Since Jul 2019
+4K
Net shares
Net buyer
$3.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
4K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+2K
Price / share
$0.90
Trade value
$1.80K
% of position
2.0%
8/17/2021
98.25K→100.25K
Common Stock
Indirect
Shares
+2K
Price / share
$0.89
Trade value
$1.78K
% of position
2.0%
8/17/2021
100.25K→102.25K
Total
Net shares
+4K
Net value
$3.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/17/2021 | P · Purchase | +2K | $0.90 | $1.80K | 2.0% | 98.25K | 100.25K |
| Common Stock Indirect | 8/17/2021 | P · Purchase | +2K | $0.89 | $1.78K | 2.0% | 100.25K | 102.25K |
| Total | +4K | $3.58K | ||||||
Derivative Transactions0
No derivative transactions reported